Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Bolis

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Oncotarget|July 16, 2016
RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cellsMaurizio Gianni, Maddalena Fratelli, Marco Bolis, et al.
Oncogene|December 13, 2018
HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive casesGabriela Paroni, Marco Bolis, Adriana Zanetti, et al.
International Journal of Molecular Sciences|January 25, 2025
Onvansertib and Navitoclax Combination as a New Therapeutic Option for Mucinous Ovarian CarcinomaSerena Petrella, Marika Colombo, Mirko Marabese, et al.
Oncotarget|May 12, 2015
MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cellsJames Neil Fisher, Mineko Terao, Maddalena Fratelli, et al.
Cell Reports|February 28, 2019
Influenza Vaccination Induces NK-Cell-Mediated Type-II IFN Response that Regulates Humoral Immunity in an IL-6-Dependent MannerYagmur Farsakoglu, Miguel Palomino-Segura, Irene Latino, et al.
Cancer Treatment Reviews|February 1, 2014
Retinoids and breast cancer: from basic studies to the clinic and back againEnrico Garattini, Marco Bolis, Silvio Ken Garattini, et al.
Cell Communication and Signaling : CCS|March 10, 2026
Orphan Nuclear Receptors expression and function in breast cancer cells: oncogenic action of the NR2F6 receptorMaria Azzurra Caricasulo, Gabriela Paroni, Adriana Zanetti, et al.
Oncogene|December 12, 2018
S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemiaMaurizio Gianni, Mineko Terao, Mami Kurosaki, et al.
Oncogene|December 8, 2022
Correction: S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemiaMaurizio Gianni, Mineko Terao, Mami Kurosaki, et al.
Cancers|October 21, 2020
Retinoic Acid Sensitivity of Triple-Negative Breast Cancer Cells Characterized by Constitutive Activation of the notch1 Pathway: The Role of RarβGabriela Paroni, Adriana Zanetti, Maria Monica Barzago, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Oncotarget|July 16, 2016
RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cellsMaurizio Gianni, Maddalena Fratelli, Marco Bolis, et al.
Oncogene|December 13, 2018
HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive casesGabriela Paroni, Marco Bolis, Adriana Zanetti, et al.
International Journal of Molecular Sciences|January 25, 2025
Onvansertib and Navitoclax Combination as a New Therapeutic Option for Mucinous Ovarian CarcinomaSerena Petrella, Marika Colombo, Mirko Marabese, et al.
Oncotarget|May 12, 2015
MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cellsJames Neil Fisher, Mineko Terao, Maddalena Fratelli, et al.
Cell Reports|February 28, 2019
Influenza Vaccination Induces NK-Cell-Mediated Type-II IFN Response that Regulates Humoral Immunity in an IL-6-Dependent MannerYagmur Farsakoglu, Miguel Palomino-Segura, Irene Latino, et al.
Cancer Treatment Reviews|February 1, 2014
Retinoids and breast cancer: from basic studies to the clinic and back againEnrico Garattini, Marco Bolis, Silvio Ken Garattini, et al.
Cell Communication and Signaling : CCS|March 10, 2026
Orphan Nuclear Receptors expression and function in breast cancer cells: oncogenic action of the NR2F6 receptorMaria Azzurra Caricasulo, Gabriela Paroni, Adriana Zanetti, et al.
Oncogene|December 12, 2018
S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemiaMaurizio Gianni, Mineko Terao, Mami Kurosaki, et al.
Oncogene|December 8, 2022
Correction: S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemiaMaurizio Gianni, Mineko Terao, Mami Kurosaki, et al.
Cancers|October 21, 2020
Retinoic Acid Sensitivity of Triple-Negative Breast Cancer Cells Characterized by Constitutive Activation of the notch1 Pathway: The Role of RarβGabriela Paroni, Adriana Zanetti, Maria Monica Barzago, et al.
Pageof 8